News

Stay up to date with the latest activity at Richmond Pharmacology

Contributing to our community in 2020

December 2020

Richmond Pharmacology has a long-standing tradition of supporting local, national, and international charities and 2020 is no exception.

View article

Richmond Pharmacology supports Cardior Pharmaceuticals with the pioneering trial of an oligonucleotide-based drug in heart failure patients

December 2020

Richmond Pharmacology is delighted to welcome the positive Phase Ib results of Cardior Pharmaceuticals lead compound CDR132L for heart failure.

View article

Marking a milestone for gene editing

November 2020

We are pleased to share that Richmond Pharmacology, in partnership with Intellia Therapeutics and the Royal Free Hospital, have treated the first patient in a landmark CRISPR/Cas9 clinical trial of NTLA-2001

View article

Richmond Pharmacology is delighted to confirm partnership with Intellia Therapeutics

October 2020

Phase I study of Intellia Therapeutic’s NTLA-2001 for the treatment of hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN)

View article

Richmond Pharmacology supports ReViral with the development of Sisunatovir

September 2020

ReViral has confirmed the FDA has granted Fast Track designation to Sisunatovir.

View article

Richmond Pharmacology helps UK patients gain early access to ultra-rare disease drug Lumasiran

August 2020

Richmond Pharmacology early phase drug development update.

View article

More about us Adaptive Phase I, II & III Bridging Studies TQT Studies Patient Recruitment

Meet the experts

Richmond Pharmacology has a team of experts with extensive knowledge of clinical research trials.

Latest Publications

View our latest peer-reviewed publications from a selection of our clinical trials.

Latest Videos

Learn more about Richmond Pharmacology by viewing some of our videos.

Latest news

Upcoming Event

The 41st Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT)

4 – 5 December 2020

The 41st Annual Scientific meeting focuses on international collaboration in the pursuit of drug discovery and drug development.

View event

Contributing to our community in 2020

December 17, 2020

Richmond Pharmacology has a long-standing tradition of supporting local, national, and international charities and 2020 is no exception.

Richmond Pharmacology supports Cardior Pharmaceuticals with the pioneering trial of an oligonucleotide-based drug in heart failure patients

December 14, 2020

Richmond Pharmacology is delighted to welcome the positive Phase Ib results of Cardior Pharmaceuticals lead compound CDR132L for heart failure.

Marking a milestone for gene editing

November 10, 2020